Literature DB >> 8164014

Sensitivities and predictive values of paraclinical tests for diagnosing multiple sclerosis.

G Filippini1, G C Comi, V Cosi, L Bevilacqua, M Ferrarini, V Martinelli, R Bergamaschi, M Filippi, A Citterio, L D'Incerti.   

Abstract

The sensitivities and predictive values of visual, somatosensory, and brain auditory evoked potentials (EPs), cerebrospinal fluid oligoclonal banding (CSF-OB) and magnetic resonance imaging (MRI) were evaluated for the early diagnosis of clinically definite multiple sclerosis (CDMS). Paraclinical evidence of asymptomatic lesions allows a diagnosis of CDMS. Eighty-two patients in whom MS was suspected but diagnosis of CDMS was not possible entered the study prospectively. Paraclinical examinations were performed at entry. Patients were examined and underwent EPs every 6 months, and MRI yearly. After a mean follow-up of 2.9 years, 28 patients (34%) had developed CDMS (McDonald-Halliday criteria). The initial MRI was strongly suggestive of MS in 19 of these (68%), while 27 (96%) had at least one MS-like abnormality in the initial MRI. CSF-OB and EPs had lower sensitivities. CDMS developed during follow-up in 19 of the 36 patients (53%) who had an initial MRI strongly suggestive of MS but in only 1 of the 25 who had normal MRI when first studied. These results support previous conclusions that MRI is the most sensitive test for detecting white matter asymptomatic lesions, and the most predictive for the diagnosis of CDMS.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8164014     DOI: 10.1007/bf00868339

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  24 in total

1.  Multiple sclerosis: magnetic resonance imaging, evoked responses, and spinal fluid electrophoresis.

Authors:  M R Farlow; O N Markand; M K Edwards; J C Stevens; O J Kolar
Journal:  Neurology       Date:  1986-06       Impact factor: 9.910

2.  Correlation between multimodal evoked potentials and magnetic resonance imaging in multiple sclerosis.

Authors:  G Comi; V Martinelli; S Medaglini; T Locatelli; M Filippi; N Canal; F Triulzi; A Del Maschio
Journal:  J Neurol       Date:  1989-01       Impact factor: 4.849

Review 3.  Diagnosis and classification of multiple sclerosis.

Authors:  W I McDonald; A M Halliday
Journal:  Br Med Bull       Date:  1977-01       Impact factor: 4.291

4.  Risk of developing multiple sclerosis after uncomplicated optic neuritis: a long-term prospective study.

Authors:  J F Rizzo; S Lessell
Journal:  Neurology       Date:  1988-02       Impact factor: 9.910

5.  The predictive value of cerebrospinal fluid electrophoresis in 'possible' multiple sclerosis.

Authors:  D Moulin; D W Paty; G C Ebers
Journal:  Brain       Date:  1983-12       Impact factor: 13.501

6.  CSF electrophoresis in one thousand patients.

Authors:  G C Ebers; D W Paty
Journal:  Can J Neurol Sci       Date:  1980-11       Impact factor: 2.104

7.  Magnetic resonance imaging of the head in the diagnosis of multiple sclerosis: a prospective 2-year follow-up with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT.

Authors:  K H Lee; S A Hashimoto; J P Hooge; L F Kastrukoff; J J Oger; D K Li; D W Paty
Journal:  Neurology       Date:  1991-05       Impact factor: 9.910

8.  [Visual, early auditory and somatosensory evoked potentials in multiple sclerosis (917 cases)].

Authors:  C Fischer; F Mauguière; V Ibañez; J Courjon
Journal:  Rev Neurol (Paris)       Date:  1986       Impact factor: 2.607

9.  Clinical and magnetic resonance imaging in optic neuritis.

Authors:  L Jacobs; F E Munschauer; S E Kaba
Journal:  Neurology       Date:  1991-01       Impact factor: 9.910

10.  Silent brain lesions in patients with isolated idiopathic optic neuritis. A clinical and nuclear magnetic resonance imaging study.

Authors:  L Jacobs; P R Kinkel; W R Kinkel
Journal:  Arch Neurol       Date:  1986-05
View more
  13 in total

1.  Isolated demyelinating syndromes: comparison of different MR imaging criteria to predict conversion to clinically definite multiple sclerosis.

Authors:  M Tintoré; A Rovira; M J Martínez; J Rio; P Díaz-Villoslada; L Brieva; C Borrás; E Grivé; J Capellades; X Montalban
Journal:  AJNR Am J Neuroradiol       Date:  2000-04       Impact factor: 3.825

2.  Isolated optic neuritis and its prognosis for multiple sclerosis: a clinical and paraclinical study with evoked potentials. CSF examination and brain MRI.

Authors:  A Ghezzi; V Torri; M Zaffaroni
Journal:  Ital J Neurol Sci       Date:  1996-10

3.  The effect of contrast reduction on pattern-reversal VEPs in suspected multiple sclerosis and optic neuritis.

Authors:  Adrian W Davidson; Richard F Scott; Keith W Mitchell
Journal:  Doc Ophthalmol       Date:  2004-09       Impact factor: 2.379

Review 4.  The clinical role of evoked potentials.

Authors:  P Walsh; N Kane; S Butler
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-06       Impact factor: 10.154

Review 5.  Neurophysiological markers.

Authors:  Letizia Leocani; Giancarlo Comi
Journal:  Neurol Sci       Date:  2008-09       Impact factor: 3.307

Review 6.  Cerebrospinal fluid.

Authors:  E J Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-10       Impact factor: 10.154

7.  Diagnostic value of visual evoked potentials for clinical diagnosis of multiple sclerosis.

Authors:  Niphon Chirapapaisan; Sawarin Laotaweerungsawat; Wanicha Chuenkongkaew; Patthanee Samsen; Ngamkae Ruangvaravate; Atiporn Thuangtong; Nacha Chanvarapha
Journal:  Doc Ophthalmol       Date:  2014-10-21       Impact factor: 2.379

8.  Diagnostic value of paraclinical tests in multiple sclerosis: relative sensitivities and specificities for reclassification according to the Poser committee criteria.

Authors:  S Beer; K M Rösler; C W Hess
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-08       Impact factor: 10.154

9.  Tremor and Dysmetria in Multiple Sclerosis: A Neurophysiological Study.

Authors:  S H Alusi; A Macerollo; Colum D MacKinnon; John C Rothwell; Peter G Bain
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2021-07-26

10.  A prospective study of patients with brain MRI showing incidental t2 hyperintensities addressed as multiple sclerosis: a lot of work to do before treating.

Authors:  Christine Lebrun; Mikael Cohen; Annabelle Chaussenot; Lydiane Mondot; Stephane Chanalet
Journal:  Neurol Ther       Date:  2014-12-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.